Weng Q - Search Results

1

Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.

Weng Q, Zhang J, Cao J, Xia Q, Wang D, Hu Y, Sheng R, Wu H, Zhu D, Zhu H, He Q, Yang B. Weng Q, et al. Invest New Drugs. 2011 Dec;29(6):1177-87. doi: 10.1007/s10637-010-9462-y. Epub 2010 Jun 5. Invest New Drugs. 2011. PMID: 20524035

2

Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.

Jiang F, Weng Q, Sheng R, Xia Q, He Q, Yang B, Hu Y. Jiang F, et al. Among authors: weng q. Arch Pharm (Weinheim). 2007 May;340(5):258-63. doi: 10.1002/ardp.200600201. Arch Pharm (Weinheim). 2007. PMID: 17464965

3

[Q39 induces apoptosis in human leukemia cell line K562 in hypoxia].

Zhang B, Weng QJ, Chen ZT. Zhang B, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 May;36(3):261-6. doi: 10.3785/j.issn.1008-9292.2007.03.009. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007. PMID: 17571309 Chinese.

4

Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia.

Weng Q, Wang D, Guo P, Fang L, Hu Y, He Q, Yang B. Weng Q, et al. Eur J Pharmacol. 2008 Mar 10;581(3):262-9. doi: 10.1016/j.ejphar.2007.12.006. Epub 2007 Dec 15. Eur J Pharmacol. 2008. PMID: 18215659

5

CPT21, a novel compound with anti-proliferative effect against gastric cancer cell SGC7901.

Zhang B, Luo Y, Weng Q, He Q, Lu W, Yang B. Zhang B, et al. Among authors: weng q. Invest New Drugs. 2008 Dec;26(6):517-24. doi: 10.1007/s10637-008-9120-9. Epub 2008 Feb 19. Invest New Drugs. 2008. PMID: 18283417

6

VEGF and Bcl-2 interact via MAPKs signaling pathway in the response to hypoxia in neuroblastoma.

Wang D, Weng Q, Zhang L, He Q, Yang B. Wang D, et al. Among authors: weng q. Cell Mol Neurobiol. 2009 May;29(3):391-401. doi: 10.1007/s10571-008-9331-9. Epub 2008 Dec 2. Cell Mol Neurobiol. 2009. PMID: 19048366

7

Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol.

Zhu H, Ding WJ, Wu R, Weng QJ, Lou JS, Jin RJ, Lu W, Yang B, He QJ. Zhu H, et al. Cancer Invest. 2010 Jan;28(1):23-32. doi: 10.3109/07357900903095664. Cancer Invest. 2010. PMID: 19916747

8

5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis.

Xu D, Cao J, Qian S, Li L, Hu C, Weng Q, Lou J, Zhu D, Zhu H, Hu Y, He Q, Yang B. Xu D, et al. Among authors: weng q. Invest New Drugs. 2011 Oct;29(5):786-99. doi: 10.1007/s10637-010-9423-5. Epub 2010 Mar 30. Invest New Drugs. 2011. PMID: 20352292

9

XQ2, a novel TPZ derivative, induced G2/M phase arrest and apoptosis under hypoxia in non-small cell lung cancer cells.

Lou J, Zhou X, Weng Q, Wang DD, Xia Q, Hu Y, He Q, Yang B, Luo P. Lou J, et al. Among authors: weng q. Biosci Biotechnol Biochem. 2010;74(6):1181-7. doi: 10.1271/bbb.90889. Epub 2010 Jun 7. Biosci Biotechnol Biochem. 2010. PMID: 20530905 Free article.

10

Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway.

Zhang J, Cao J, Weng Q, Wu R, Yan Y, Jing H, Zhu H, He Q, Yang B. Zhang J, et al. Among authors: weng q. PLoS One. 2010 Nov 9;5(11):e13910. doi: 10.1371/journal.pone.0013910. PLoS One. 2010. PMID: 21085474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

808 results

Search Page

Filters